期刊文献+

可调钠曲线和序贯透析治疗终末期肾病伴顽固性高血压的疗效及对左心室功能的影响 被引量:6

Effects of Adjustable Sodium Curve and Sequential Dialysis on the Treatment of End-stage Renal Disease with Refractory Hypertension and Its Effect on Left Ventricular Function
下载PDF
导出
摘要 【目的】比较可调钠曲线透析和序贯透析治疗终末期肾病(EsRD)伴顽固性高血压(RH)的效果及对左心室功能的影响。【方法】40例ESRD伴RH患者随机分为可调钠曲线组(A组)和序贯透析组(B组),每组各20例。比较透析前和透析3个月后两组C反应蛋白(CRP)、白介素6(IL-6)、肿瘤坏死因子α(TNFα)、血管紧张素Ⅱ(AngⅡ),收缩压(SBP)、舒张压(DBP)、平均动脉压(MAP)、左室射血分数(LVEF)、左心室心肌质量指数(LV-MI)、左心室舒张末内径(LVEDd)差异。【结果】A组透析后AngⅡ、CRP、IL-6、TNF-α水平,MAP、SBP、DBP及LVMI、LVEDd均低于,LVEF高于B组,且两组比较差异均有显著性(P〈0.05)。【结论】可调钠曲线透析患者RH控制效果、左心室功能改善情况优于序贯透析治疗。 [Objective]To compare the effects of adjustable sodium curve and sequential dialysis on the treatment of end-stage renal disease (ESRD) with refractory hypertension (RH) and their effects on left ventricular function. [Meth- odslA total of 40 cases of patients with ESRD and RT were randomly divided into an adjustable sodium curve group (A group) and a sequential dialysis group (B group), with 20 cases in each. The levels of C reactive protein (CRP), IL-6, TNF- α, angiotensin II (Ang II), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), left ventricular ejection fraction (LVEF), left ventricular mass index (LVMI), and left ventricular end diastolic diameter (LVEDd) in both groups were determined before dialysis and 3 months after dialysis. [ResultslAfter dialysis, the levels of Ang II, CRP, IL-6, TNF-α ; MAP, SBP, DBP, LVMI, and LVEDd of group A were lower than those of group B ( P 〈0.05). The LVEF of group A was higher than that of group B ( P 〈0.05). [Conclusion] The curative effects of ESRD with RH and the improvements of left ventrieular function in patients receiving adjustable sodium curve are superior to sequential dialysis treatment.
作者 王润蕾 WANG Run-lei(The People's Hospital of Chongzhou, Shichuan Province ,611230)
出处 《医学临床研究》 CAS 2018年第6期1092-1094,共3页 Journal of Clinical Research
关键词 肾病/治疗 高血压 肾透析/方法 心室功能 Nephrosis/TH Hypertension Renal Dialysis/MT Ventricular Function Left
  • 相关文献

参考文献7

二级参考文献87

  • 1李旭,曹宁,韩敬明,王东辉.左卡尼汀对维持性血液透析患者左心肥厚的影响[J].实用医学杂志,2009,25(5):786-788. 被引量:16
  • 2刘虹,刘伏友,彭佑铭,朱健玲,李军,陈星.可调钠血液透析对透析低血压的预防作用[J].中国血液净化,2002,1(8):21-23. 被引量:123
  • 3杨秀芹,孙玉兰.血液透析加血液灌流治疗尿毒症顽固性高血压[J].中国血液净化,2004,3(8):462-462. 被引量:77
  • 4王志刚.血液净化学[M].2版.北京:北京科学技术出版社,2003:144. 被引量:9
  • 5王志刚.血液净化学[M].北京:北京科学技术出版社,2003.42R-441. 被引量:22
  • 6Calhoun DA,Jones D, Textor S, et al. Resistant hypertension:diagnosis, evaluation, and treatment. A scientific statement fromthe American Heart Association Professional Education Committeeof the Council for High Blood Pressure Research. Hypertension,2008, 51:1403-1419. 被引量:1
  • 7Chobanian AV, Bakris GL, Black HR, et al. Joint NationalCommittee on Prevention,Detection,Evaluation, and Treatmentof High Blood Pressure. National Heart, Lung, and BloodInstitute; National Heart, Lung, and Blood Institute; NationalHigh Blood Pressure Education Program Coordinating Committee.Seventh report of the Joint National Committee on prevention,detection, evaluation, and treatment of high blood pressure.Hypertension, 2003,42 : 1206-1252. 被引量:1
  • 8Dahlof B,Sever PS, Poulter NR, et al. ASCOT Investigators.Prevention of cardiovascular events with an antihypertensiveregimen of amlodipine adding perindopril as required versusatenolol adding bendroflumethiazide as required, in the AngloScandinavian Cardiac Outcomes Trial-Blood Pressure LoweringArm ( ASCOT-BPLA) : a multicentre randomised controlled trial.Lancet,2005,366 : 895 -906. 被引量:1
  • 9Jamerson K,Weber MA, Bakris GL, et al. ACCOMPLISH TrialInvestigators. Benazepril plus amlodipine or hydrochlorothiazidefor hypertension in high-risk patients. N Engl J Med,2008,359:2417-2428. 被引量:1
  • 10Schmieder RE,Redon J, Grassi G,et al. ESH position paper:renal denervation - an interventional therapy of resistanthypertension. J Hypertens, 2012, 30:837-841. 被引量:1

共引文献91

同被引文献41

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部